Xylo Technologies (DB:2QM) - Stock Price, News & Analysis

2QM Stock Overview

A technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. More details

2QM fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Revenue is forecast to grow 34.36% per year

Risk Analysis

Earnings have declined by 14.5% per year over past 5 years

Does not have a meaningful market cap (€2M)

Shares are highly illiquid

Shareholders have been diluted in the past year

Xylo Technologies Ltd Competitors

MagForce

XTRA:MF6

€3.6m

Audientes

DB:AUG

€6.9m

MagForce

DB:MF6

€366.9k

Geratherm Medical

XTRA:GME

€15.1m

Price History & Performance

Summary of all time highs, changes and price drops for Xylo Technologies
Historical stock prices
Current Share Price	US$4.37
52 Week High	US$5.92
52 Week Low	US$3.52
Beta	1.46
11 Month Change	0%
3 Month Change	-19.61%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-18.00%

Recent updates

Shareholder Returns

	2QM	DE Medical Equipment	DE Market
7D	0%	-3.7%	-0.5%
1Y	n/a	-4.2%	8.3%

Return vs Industry: Insufficient data to determine how 2QM performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 2QM performed against the German Market.

Price Volatility

Is 2QM's price volatile compared to industry and market?
2QM volatility
2QM Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	5.8%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.0%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 2QM's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 2QM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	84	Liron Carmel	www.medigus.com

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.

Xylo Technologies Ltd Fundamentals Summary

How do Xylo Technologies's earnings and revenue compare to its market cap?
2QM fundamental statistics
Market cap	€2.17m
Earnings (TTM)	-€14.79m
Revenue (TTM)	€53.30m

0.0x

P/S Ratio

-0.1x

P/E Ratio

Is 2QM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2QM income statement (TTM)
Revenue	US$57.64m
Cost of Revenue	US$49.84m
Gross Profit	US$7.80m
Other Expenses	US$23.79m
Earnings	-US$15.99m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-21.84
Gross Margin	13.53%
Net Profit Margin	-27.74%
Debt/Equity Ratio	40.7%

How did 2QM perform over the long term?

See historical performance and comparison

Xylo Technologies DB:2QM Stock Report